PLASMABLASTIC LYMPHOMA
Clinical trials for PLASMABLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PLASMABLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for PLASMABLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo targets hard-to-treat lymphoma in early trial
Disease control Recruiting nowThis study tests whether adding daratumumab to standard drugs (bortezomib and dexamethasone) can shrink tumors in people with plasmablastic lymphoma, a rare and aggressive blood cancer, that has returned or not responded to prior therapy. About 28 adults will receive the combinat…
Matched conditions: PLASMABLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control
Last updated May 01, 2026 15:41 UTC
-
New drug SGR-1505 enters human testing for B-Cell cancers
Disease control Recruiting nowThis early-phase trial tests a new drug called SGR-1505 in adults with various B-cell blood cancers (like lymphoma and leukemia). The main goals are to find the safest dose and understand side effects. About 98 participants will receive the drug, and researchers will monitor how …
Matched conditions: PLASMABLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
New hope for HIV patients with aggressive lymphoma
Disease control Recruiting nowThis early-phase study tests whether adding the drug pomalidomide to standard chemotherapy (with or without rituximab) is safe and effective for people with HIV who have certain aggressive lymphomas. About 25 adults with high-risk features will receive up to 6 cycles of treatment…
Matched conditions: PLASMABLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC